First clinical experiences with the tetravalent live vaccine against dengue (Qdenga ®) in travellers: a multicentric TravelMedVac study in Germany.
Sign Up to like & getrecommendations! Published in 2025 at "Journal of travel medicine"
DOI: 10.1093/jtm/taaf004
Abstract: BACKGROUND A study was conducted to assess the safety and tolerability of the tetravalent live-attenuated dengue vaccine Qdenga®, which received marketing approval in Germany in 2022. The study evaluated vaccine-related reactions in a predominantly dengue-naïve… read more here.
Keywords: germany; dengue; tetravalent live; vaccine ... See more keywords
Current Development and Challenges of Tetravalent Live-Attenuated Dengue Vaccines
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2022.840104
Abstract: Dengue is the most common arboviral disease caused by one of four distinct but closely related dengue viruses (DENV) and places significant economic and public health burdens in the endemic areas. A dengue vaccine will… read more here.
Keywords: tetravalent live; current development; dengue; dengue vaccines ... See more keywords